Skip to main content
. 2020 Jun 18;12(6):566. doi: 10.3390/pharmaceutics12060566
ASD artificial stomach-duodenum model
AUC area under the curve
BCS biopharmaceutics classification system
Cmax maximal concentration
CO2 carbon dioxide
CYP Cytochrome P450
DS degree of supersaturation
EMA European Medicines Agency
FaSSGF fasted state simulated gastric fluids
FaSSIF-v1 fasted state simulated intestinal fluids version 1
GI gastrointestinal
GIS gastrointestinal simulator
GISDuodenum duodenal chamber of the GIS
GISJejunum jejunal chamber of the GIS
GISStomach gastric chamber of the GIS
HPLC high-performance liquid chromatography
HRM high-resolution manometry
IR immediate-release
ksec_d secretion rate constant constant occuring in the duodenal chamber of the GIS
ksec_s secretion rate constant constant occuring in the gastric chamber of the GIS
M&S modeling and simulation
MTA mass transport analysis
PBBM physiologically-based biopharmaceutics modeling
PBPK physiologically-based pharmacokinetics modeling
PDMA Pharmaceuticals and Medical Devices Agency
PK pharmacokinetics
PPI proton-pump inhibitor
RLD reference listed drug
t1/2,G gastric half-life of emptying
TFA trifluoroacetic acid
U.S. FDA United States Food and Drug Administration
USP United States Pharmacopoeia
Vd volume in the duodenal chamber of the GIS
Vj volume in the jejunal chamber of the GIS
Vs volume in the gastric chamber of the GIS
Z_D duodenal dissolution coefficient, considering the pH-dependent dissolution and solubility of loratadine
Z_J jejunal dissolution coefficient, considering the pH-dependent dissolution and solubility of loratadine
Z_S gastric dissolution coefficient, considering the pH-dependent dissolution and solubility of loratadine